Aidigong Maternal & Child Health Limited provided earnings guidance for the year ended 31 December 2022. For the year, the company is expected to record a consolidated net loss of not more than HKD 180 million, while the net profit for the same period in 2021 was approximately HKD 35 million. The net loss for the financial year was mainly due to (i) finance costs of approximately HKD 63 million for the fiscal year 2022, which included non-cash expenses of approximately HKD 19 million for interest on lease liabilities; (ii) the increase in non-cash expenses related to the share incentive scheme of approximately HKD 40 million; (iii) the decrease in gain on disposal of subsidiaries and associates for the fiscal year 2022 as compared with the previous financial year; (iv) disposed real estate business that incurred expenses prior to its disposal; and (v) impact of the COVID-19 pandemic on all of the Group's postpartum care centre stores in varying degrees which resulted in the customers being unable to check in as scheduled, coupled with increased investment costs for store opening of new brand for the fiscal year 2022, thereby affecting the gross profit and profit.